Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novo Ventures' Hot Streak Of Exits

This article was originally published in Start Up

Executive Summary

The evergreen fund is on a hot streak thanks to a recent string of exits.

You may also be interested in...



Project Sigma: Wellcome Funding For Scientific Research

The Wellcome Trust, the UK’s largest private funder of biomedical research, has hired industry veterans to run a new £200 million evergreen fund that will take full ownership of biotech start-ups and hold them with more patience than VCs can afford.

Hoping Drugs Take Root, Alder Raises $38 Million Round

The Bothell, Wash.-based antibody developer will study a Phase II interleukin-6 inhibitor in cancer indications, and will bring a new migraine drug into the clinic. The IL-6 drug is already partnered with BMS in a lucrative deal for autoimmune indications.

Wellcome Trust Launches £200 Million Fund For Diverse Health Care Investments

The U.K.’s largest charitable foundation for biomedical research is the sole investor in a new fund that will target start-ups as well as later-stage growth opportunities across the health care spectrum.

Related Content

Topics

Related Companies

Related Deals

UsernamePublicRestriction

Register

SC091895

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel